Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
Mercoledì 4 ottobre 2023
circa 1 minuti di lettura
Journal and Affiliations:
Nature, =luglio 2020
Dora Pinto, Humabs BioMed, Bellinzona
Martina Beltramello, Humabs BioMed, Bellinzona
Siro Bianchi, Humabs BioMed, Bellinzona
Stefano Jaconi, Humabs BioMed, Bellinzona
Katja Culap, Humabs BioMed, Bellinzona
Fabrizia Zatta, Humabs BioMed, Bellinzona
Anna De Marco, Humabs BioMed, Bellinzona
Alessia Peter, Humabs BioMed, Bellinzona
Barbara Guarino, Humabs BioMed, Bellinzona
Elisabetta Cameroni, Humabs BioMed, Bellinzona
Antonio Lanzavecchia, Humabs BioMed, Bellinzona e Istituto di Ricerca in Biomedicina, USI, Bellinzona
Katja Fink, Humabs BioMed, Bellinzona
Davide Corti, Humabs BioMed, Bellinzona
Tags:
SARS-CoV-2
Authors:
Alessia Peter
Anna De Marco
Antonio Lanzavecchia
Barbara Guarino
Davide Corti
Dora Pinto
Elisabetta Cameroni
Fabrizia Zatta
Katja Culap
Katja Fink
Martina Beltramello
Siro Bianchi
Stefano Jaconi